(icTV) Interview with Alain Combes
Is it possible and safe to deliver “super-protective” ventilatory strategies integrated by ECCO2R in patients with ARDS?
To answer this question, the ESICM Trials Group conducted the SUPERNOVA study, a pilot multicentre international trial. Alain Combes (Paris, France) talks about preliminary results that he presented alongside Marco Ranieri (Rome, Italy) at LIVES 2017 during the Hot Topics Session.
This presentation at the Hot Topics session at LIVES 2017 will be available on e-LIVES.
To learn more about SUPERNOVA, click here.